human-immunodeficiency-virus-hiv

Documents about human-immunodeficiency-virus-hiv

• Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)#892567ClinicalTrials.gov
• MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo#803098ClinicalTrials.gov
• A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)#876216ClinicalTrials.gov
• A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants#883658ClinicalTrials.gov
• Explainable AI-driven comparative analysis of machine learning models for predicting HIV viral nonsuppression in Ugandan patients : retrospective cross-sectional study#425973University of Pretoria Repository
• Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment#836786ClinicalTrials.gov
• The Role of Age in Subclinical Atherosclerosis in Asian People Living with Human Immunodeficiency Virus#450667S-Space: Seoul National University
• Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers#800189ClinicalTrials.gov
• PositiveLinks for Youth (PL4Y) for Texas#889066ClinicalTrials.gov
• A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules#283082ClinicalTrials.gov
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose#346991ClinicalTrials.gov
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)#849273ClinicalTrials.gov
• A Clinical Study to Evaluate the Safety and Immunogenicity of a Higher Dose of the Study Vaccine, VIR-1388, in HCMV-seropositive Adult Participants Without HIV#868617ClinicalTrials.gov
• Development Model of Family Empowerment and Peer Group Support in Independence of Caring on Indonesian's Migrant Worker (TKI) Infected by HIV#1004702Jurnal Ners
• Characteristics of new mutations in the integrase gene and in the 3'PPT of the Human Immunodeficiency Virus in the resistance mechanism#156105HAL (France)
• Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV#398196ClinicalTrials.gov
• Link4Health: A Combination Strategy for Linkage and Retention, Swaziland#966826ClinicalTrials.gov
• Maternal mental health and caregiver competence of HIV-positive and negative women caring for their singleton newborns in KwaZulu-Natal Province, South Africa#197765University of Pretoria Repository
• Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures#1033025ClinicalTrials.gov
• Pre-Approval Access to Rilpivirine Long Acting (RPV LA) Injectable Suspension for the Treatment of a Participant With Human Immunodeficiency Virus (HIV)-1 Infection#858722ClinicalTrials.gov
• An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children#912283ClinicalTrials.gov
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)#904840ClinicalTrials.gov
• The incidence of, and risk factors for, liver injury in adults living with human immunodeficiency virus initiating antiretroviral therapy in a South African private sector managed care cohort#196983OpenUCT
• The exposome perspective : environmental and infectious agents as drivers of cancer disparities in low- and middle-income countries#687086University of Pretoria Repository
• Study of Doravirine/Islatravir (DOR/ISL 100 mg/0.75 mg) to Evaluate the Antiretroviral Activity, Safety, and Tolerability in Treatment-Naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)#803109ClinicalTrials.gov
• Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years#904028ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy#253159ClinicalTrials.gov
• Views, barriers, and facilitators of people living with human immunodeficiency virus and healthcare professionals regarding the use of a mobile health application to improve HIV self-care in Malaysia.#221879NCBI PubMed Central
• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of LP-98 Injection in Healthy Subjects#829621ClinicalTrials.gov
• Characterization of the conformational state and flexibility of HIV-1 glycoprotein gp120 core domain#954416Koc University Digital Collections
• The OPENS Trial: Offering Women PrEP (Aim 1)#913301ClinicalTrials.gov
• Non Invasive Oral Cancer Screening Among HIV Infected Individuals#980532ClinicalTrials.gov
• Assessment of health care workers’ attitudes and perceptions towards voluntary medical male circumcision at Ugu District, KwaZulu-Natal.#323732ResearchSpace
• Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults#390969ClinicalTrials.gov
• Safety and Efficacy of Allogenic Adoptive Immune Therapy for Immune Reconstitution in Chronic HIV-1 Infected Patients#854018ClinicalTrials.gov
• A Study to Assess the Efficacy of Raltegravir (Isentress®), Administered in Combination With Other Antiretroviral Drugs as Treatment for Adults and Older Adults Infected With the Human Immunodeficiency Virus 1 (HIV-1)(MK-0518-145) (Wirksamkeit Von Isentress® Unter Praxisbedingungen)#383495ClinicalTrials.gov
• Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults#908298ClinicalTrials.gov
• Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections#910955ClinicalTrials.gov
• The anatomical basis and rational for the transoral approach during the surgical excision of the sublingual salivary gland for the management of plunging ranula#197793University of Pretoria Repository
• When Unilateral Leg Swelling is Not Deep Vein Thrombosis: A Case of Disseminated Kaposi Sarcoma Revealing Advanced Human Immunodeficiency Virus#465419ODU Digital Commons
• Exploiting the molecular basis of oesophageal cancer for targeted therapies and biomarkers for drug response : guiding clinical decision-making#824447University of Pretoria Repository
• A qualitative exploration of psychosocial determinants influencing viral load suppression among adolescents living with HIV: Application of social action theory#467461African Journals Online
• A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in Lesotho#896970ClinicalTrials.gov
• Utility of the brief Patient Health Questionnaire-2 and Generalized Anxiety Disorder-2 screeners for depression and generalized anxiety symptom identification in people with human immunodeficiency virus.#9940PubMed
• Maternal-to-child- transmission of human immunodeficiency virus in maternal preterm premature rupture of the membranes: A Systematic review#372633ULRR
• Immunophenotypic and Molecular Features of TP53 in Diffuse Large B-Cell Lymphoma (DLBCL)#477926WIReDSpace
• KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)#900595ClinicalTrials.gov
• Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-1)#872401ClinicalTrials.gov
• Infrastructural and human-resource factors associated with return of infant HIV test results to caregivers: secondary analysis of a nationally representative situational assessment, South Africa, 2010#372701University of Pretoria Repository
• Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya#867891ClinicalTrials.gov